Biotech Values

[biomaven0]

>>Gammagard AD

I'd add that this is another "break the bank" and then some treatment - Gammagard is inherently extremely expensive to produce and administer and it's not even clear they could ramp up production by the two orders of magnitude or more (which would be needed if this were successful) even if they wanted to.

Incidentally Halozyme has a partnership w/ Baxter for an injectible form of Gammagard.

Peter